Evidence map›Paper›PMID 32211196›Full record

ArticleFungal biology and biotechnology2020

Promoter tools for further development of

Maiko Umemura, Kaoru Kuriiwa, Linh Viet Dao, Tetsuya Okuda, Goro Terai

Open access · goldAbstract read
In one paragraph

Article in Fungal biology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Synthetic and systems biotechnology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Increasing NADPH impairs fungal HBioresources and bioprocessing · 2022
    Article
  11. New Promoters for Metabolic Engineering ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  12. Fungal research in Japan: tradition and future.Fungal biology and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Maiko Umemura1Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, 305-8566 Japan.ORCID 0000-0001-8730-1380
Kaoru Kuriiwa1Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, 305-8566 Japan.
Linh Viet Dao1Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, 305-8566 Japan.
Tetsuya Okuda1Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, 305-8566 Japan.
Goro Terai4Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba, 277-8561 Japan.
Chiba University · JPNational Institute of Advanced Industrial Science and Technology · JPNational Museum of Nature and Science · JPNational University of Singapore · SGThe Open University of Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe filamentous fungus

resultsTo test the ability of the promoters of the top 6 genes to induce production of a fungal secondary metabolite, ustiloxin B, we inserted the promoters before the start codon of

conclusionWe newly reported two sequences as promoter tools for secondary metabolite production in

Indexed as

Aspergillus oryzaePromoterSecondary metabolite production

Identifiers

PMID32211196
PMCPMC7092444
OpenAlexW3013966638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.